We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Neutron Analysis of Glaucoma Drugs Could Help Aggressive Cancer Drug Design

News   Feb 13, 2018 | Original story from Oak Ridge National Laboratory

 
Neutron Analysis of Glaucoma Drugs Could Help Aggressive Cancer Drug Design

This image shows the active site of hCA II. The active site is flanked by hydrophilic (violet) and hydrophobic (green) binding pockets that can be used to design specific drugs targeting cancer-associated hCAs. Five clinical drugs are shown superimposed in the hCA II active site, based on room-temperature neutron structures. Credit: (ORNL/Andrey Kovalevsky)

 
 
 

RELATED ARTICLES

Breast Cancer Vulnerability Could Be Exploited by Future Targeted Drugs

News

Researchers have identified a vulnerability in some breast cancer cells of a certain type – called triple negative breast cancer – that could be exploited by future targeted drugs.

READ MORE

Scientists Develop Platform to Kill Cancer Cells

News

For the first time ever, scientists have shown that a hybrid nanomaterial based on magnetite-gold particles can serve as a universal platform to both detect cancer cells anywhere in the body and to complete targeted deliveries of drugs to these cells.

READ MORE

How a 'Jellyfish'-shaped Structure Relieves Pressure in Your Cells

News

Scientists have solved the structure of a key protein that senses volume changes in cells.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE